Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2011, Article ID 705305, 6 pages
http://dx.doi.org/10.1155/2011/705305
Review Article

Well-Differentiated Thyroid Carcinomas: Management of the Central Lymph Node Compartment and Emerging Biochemical Markers

1Endocrine Surgery Unit, Department of Surgery, Alfred Hospital, Monash University, Brighton, Melbourne, VIC 3186, Australia
2Divisions of General Surgery and Surgical Oncology, Departments of Surgery and Oncology, University of Calgary, Calgary, AB, Canada T2N 2T9

Received 30 June 2011; Accepted 7 August 2011

Academic Editor: Michiel W. M. van den Brekel

Copyright © 2011 Meei J. Yeung and Janice L. Pasieka. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Sipos and E. L. Mazzaferri, “Thyroid cancer epidemiology and prognostic variables,” Clinical Oncology, vol. 22, no. 6, pp. 395–404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Davies and H. G. Welch, “Increasing incidence of thyroid cancer in the United States, 1973-2002,” Journal of the American Medical Association, vol. 295, no. 18, pp. 2164–2167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Tuttle and R. Leboeuf, “Follow up approaches in thyroid cancer: a risk adapted paradigm,” Endocrinology and Metabolism Clinics of North America, vol. 37, no. 2, pp. 419–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Y. Bilimoria, D. J. Bentrem, C. Y. Ko et al., “Extent of surgery affects survival for papillary thyroid cancer,” Annals of Surgery, vol. 246, no. 3, pp. 375–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. I. D. Hay, C. S. Grant, E. J. Bergstralh et al., “Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?” Surgery, vol. 124, no. 6, pp. 958–966, 1998. View at Google Scholar · View at Scopus
  8. R. S. Sippel and H. Chen, “Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer,” Thyroid, vol. 19, no. 12, pp. 1373–1380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Tala and R. M. Tuttle, “Contemporary post surgical management of differentiated thyroid carcinoma,” Clinical Oncology, vol. 22, no. 6, pp. 419–429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. M. Tuttle, H. Tala, J. Shah et al., “Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American thyroid association staging system,” Thyroid, vol. 20, no. 12, pp. 1341–1349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Aygun, “Imaging of recurrent thyroid cancer,” Otolaryngologic Clinics of North America, vol. 41, no. 6, pp. 1095–1106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Shin and M. Milas, “Detection of disease recurrence in differentiated thyroid cancer,” Minerva Chirurgica, vol. 65, no. 1, pp. 101–116, 2010. View at Google Scholar · View at Scopus
  13. A. Sabet and M. Kim, “Postoperative management of differentiated thyroid cancer,” Otolaryngologic Clinics of North America, vol. 43, no. 2, pp. 329–351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Spencer, M. Takeuchi, M. Kazarosyan et al., “Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 4, pp. 1121–1127, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. J. K. Chung, Y. J. Park, T. Y. Kim et al., “Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation,” Clinical Endocrinology, vol. 57, no. 2, pp. 215–221, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Pacini, E. Molinaro, M. G. Castagna et al., “Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 8, pp. 3668–3673, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. R. McHenry and R. Phitayakorn, “Difficult problems in thyroid cancer surgery,” Minerva Chirurgica, vol. 65, no. 1, pp. 83–93, 2010. View at Google Scholar · View at Scopus
  18. B. M. Sadowski, S. K. Snyder, and T. C. Lairmore, “Routine bilateral central lymph node clearance for papillary thyroid cancer,” Surgery, vol. 146, no. 4, pp. 696–703, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. G. Senyurek, F. Tunca, H. Boztepe, F. Alagöl, T. Terzioglu, and S. Tezelman, “The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection,” Surgery, vol. 146, no. 6, pp. 1188–1195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. W. Qubain, S. Nakano, M. Baba, S. Takao, and T. Aikou, “Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma,” Surgery, vol. 131, no. 3, pp. 249–256, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Leboulleux, C. Rubino, E. Baudin et al., “Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 10, pp. 5723–5729, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C. I. Lundgren, P. Hall, P. W. Dickman, and J. Zedenius, “Clinically significant prognostic factors for differentiated thyroid carcinoma: a populationed-based, nested case-control study,” Cancer, vol. 106, no. 3, pp. 524–531, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. E. Carty, D. S. Cooper, G. M. Doherty et al., “Consensus statement on the terminology and classification of central neck dissection for thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1153–1158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Fritze and G. M. Doherty, “Surgical management of cervical lymph nodes in differentiated thyroid cancer,” Otolaryngologic Clinics of North America, vol. 43, no. 2, pp. 285–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Sywak, L. Cornford, P. Roach, P. Stalberg, S. Sidhu, and L. Delbridge, “Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer,” Surgery, vol. 140, no. 6, pp. 1000–1007, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. E. L. Mazzaferri, G. M. Doherty, and D. L. Steward, “The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma,” Thyroid, vol. 19, no. 7, pp. 683–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Carling, W. D. Long, and R. Udelsman, “Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer,” Current Opinion in Oncology, vol. 22, no. 1, pp. 30–34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. H. C. Davidson, B. J. Park, and J. T. Johnson, “Papillary thyroid cancer: controversies in the management of neck metastasis,” Laryngoscope, vol. 118, no. 12, pp. 2161–2165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. L. White and G. M. Doherty, “Level VI lymph node dissection for papillary thyroid cancer,” Minerva Chirurgica, vol. 62, no. 5, pp. 383–393, 2007. View at Google Scholar · View at Scopus
  30. M. L. White, P. G. Gauger, and G. M. Doherty, “Central lymph node dissection in differentiated thyroid cancer,” World Journal of Surgery, vol. 31, no. 5, pp. 895–904, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Arturi, D. Russo, D. Giuffrida et al., “Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1638–1641, 1997. View at Google Scholar · View at Scopus
  32. K. C. Loh, F. S. Greenspan, L. Gee, T. R. Miller, and P. P. B. Yeo, “Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 11, pp. 3553–3562, 1997. View at Google Scholar · View at Scopus
  33. M. A. Kouvaraki, S. E. Shapiro, B. D. Fornage et al., “Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer,” Surgery, vol. 134, no. 6, pp. 946–955, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Ito, T. Jikuzono, T. Higashiyama et al., “Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe,” World Journal of Surgery, vol. 30, no. 10, pp. 1821–1828, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Bonnet, D. Hartl, S. Leboulleux et al., “Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 4, pp. 1162–1167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Wada, Q. Y. Duh, K. Sugino et al., “Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection,” Annals of Surgery, vol. 237, no. 3, pp. 399–407, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Gemsenjäger, A. Perren, B. Seifert, G. Schüler, I. Schweizer, and P. U. Heitz, “Lymph node surgery in papillary thyroid carcinoma,” Journal of the American College of Surgeons, vol. 197, no. 2, pp. 182–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Zetoune, X. Keutgen, D. Buitrago et al., “Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis,” Annals of Surgical Oncology, pp. 1–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. L. Roh, J. Y. Park, and C. I. Park, “Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone,” Annals of Surgery, vol. 245, no. 4, pp. 604–610, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Gupta and S. Y. Chia, “Circulating thyroid cancer markers,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 14, no. 5, pp. 383–388, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. B. A. Ditkoff, M. R. Marvin, S. Yemul et al., “Detection of circulating thyroid cells in peripheral blood,” Surgery, vol. 120, no. 6, pp. 959–965, 1996. View at Google Scholar · View at Scopus
  42. R. P. M. Biscolla, J. M. Cerutti, and R. M. B. Maciel, “Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 10, pp. 3623–3627, 2000. View at Google Scholar · View at Scopus
  43. M. D. Ringel, P. W. Ladenson, and M. A. Levine, “Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 12, pp. 4435–4442, 1998. View at Google Scholar · View at Scopus
  44. M. Milas, J. Shin, M. Gupta et al., “Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples,” Annals of Surgery, vol. 252, no. 4, pp. 643–650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Milas, P. Mazzaglia, S. Y. Chia et al., “The utility of peripheral thyrotropin mRNA in the diagnosis of follicular neoplasms and surveillance of thyroid cancers,” Surgery, vol. 141, no. 2, pp. 137–146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Yip, E. Kebebew, M. Milas et al., “Summary statement: utility of molecular marker testing in thyroid cancer,” Surgery, vol. 148, no. 6, pp. 1313–1315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Cantara, M. Capezzone, S. Marchisotta et al., “Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 3, pp. 1365–1369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Yip, M. N. Nikiforova, S. E. Carty et al., “Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation,” Surgery, vol. 146, no. 6, pp. 1215–1223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Elisei, C. Ugolini, D. Viola et al., “BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 10, pp. 3943–3949, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Xing, D. Clark, H. Guan et al., “BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer,” Journal of Clinical Oncology, vol. 27, no. 18, pp. 2977–2982, 2009. View at Publisher · View at Google Scholar · View at Scopus